If you’re one of the 116 million Americans that Cleveland Clinic data suggests have been diagnosed with high blood pressure, the U.S. Food and Drug Administration (FDA) has a warning that one ...
Objective: To compare the haemodynamic effects of nebivolol, a highly selective antagonist of 1-adrenergic receptors with additional actions caused via the L-arginine/nitric oxide pathway ...
Purpose. The pharmacology, pharmacokinetics, efficacy, safety, and place in therapy of nebivolol are reviewed. Summary. Nebivolol, a third-generation, highly β 1-specific β-blocker, is labeled ...
HIV-1 infection, vascular endothelial function, and exercise. Effects of nebivolol on ET-1 vasoconstrictor tone. Nebivolol and endothelial regulation of fibrinolysis. Overweight/obesity and vascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback